NeuroOne Medical Technologies Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.6M | $6.9M |
| FY2022 | — | $9.6M | $8.2M |
| FY2023 | — | $6.2M | $5.3M |
| FY2024 | — | $822.0K | $1.5M |
| FY2025 | — | $7.1M | $6.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $6.6M | $6.9M |
| FY2022 | — | $9.6M | $8.2M |
| FY2023 | — | $6.2M | $5.3M |
| FY2024 | — | $822.0K | $1.5M |
| FY2025 | — | $7.1M | $6.6M |